1 |
任成山,卞士柱,胡明冬. 肺动脉高压的成因及治疗新理念[J/CD]. 中华肺部疾病杂志(电子版), 2023, 16(1): 1-5.
|
2 |
Kovacs G, Dumitrescu D, Held M, et al. Definition, clinical classification and initial diagnosis of pulmonary hypertension: Updated recommendations from the Cologne Consensus Conference 2018[J]. Int J Cardiol, 2018, 272S: 11-19.
|
3 |
Paul MH. Pulmonary arterial hypertension[J]. N Engl J Med, 2021, 385(25): 2361-2376.
|
4 |
Eyries M, Montani D, Soubrier F, et al. EIF2AK4 mutations cause pulmonary veno-occlusive disease, a recessive form of pulmonary hypertension[J]. Nat Genet, 2014, 46(1): 65-69.
|
5 |
Wang T, Zheng X, Zeng HS, et al. Integrated bioinformatic analysis reveals YWHAB as a novel diagnostic biomarker for idiopathic pulmonary arterial hypertension[J]. J Cel Physiol, 2019, 234(5): 6449-6462.
|
6 |
Risbano MG, Meadows CA, Bull TM, et al. Altered immune phenotype in peripheral blood cells of patients with scleroderma-associated pulmonary hypertension[J].ClinTransl Sci, 2010, 3(5): 210-218.
|
7 |
Nasim MT, Ogo T, Machado RD, et al. Molecular genetic characterization of SMAD signaling molecules in pulmonary arterial hypertension[J]. Hum Mutat, 2011, 32(12): 1385-1389.
|
8 |
Ruopp NF, Cockrill BA. Diagnosis and treatment of pulmonary arterial hypertension: a review[J]. JAMA, 2022, 327(14): 1379-1391.
|
9 |
Ritchie ME, Phipson B, Wu D, et al. Limma powers differential expression analyses for RNA-sequencing and microarray studies[J]. Nucleic Acids Res, 2015, 43(7): e47.
|
10 |
Yu G, Wang LG, He QY, et al. Cluster profiler: An R package for comparing biological themes among gene clusters[J].OMICS, 2012, 16(5): 284-287.
|
11 |
Satija R, Farrell JA, Regev A, et al. Spatial reconstruction of single-cell gene expression data[J]. Nat Biotechnol, 2015, 33(5): 495-502.
|
12 |
Aran D, Looney AP, Liu L, et al. Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage[J]. Nat Immunol, 2019, 20(2): 163-172.
|
13 |
谢锦程,肖梦媛,陈建英,等. 肺动脉高压实验模型的研究进展[J]. 中国比较医学杂志,2023, 33(9): 79-89.
|
14 |
陈晓毅,尹雪霞,刘 静,等. 阻塞性睡眠呼吸暂停低通气综合征并发肺动脉高压的危险因素及预测分析[J/CD]. 中华肺部疾病杂志(电子版), 2024, 17(1): 41-45.
|
15 |
张惠芳,方莲花,杜冠华. 免疫炎症反应在肺动脉高压中作用的研究进展[J]. 中国药理学通报,2015, 31(11): 1481-1484.
|
16 |
Cracowski JL, Chabot F, Labarère J, et al. Proinflammatory cytokine levels are linked to death in pulmonary arterial hypertension[J]. Eur Respir J, 2014, 43(3): 915-917.
|
17 |
马文德,苏晓灵,白玉婷. 巨噬细胞在肺动脉高压形成中的研究进展[J]. 心肺血管病杂志,2024, 43(2): 207-210.
|
18 |
李菲菲,黄钰钦,陈若霞,等. 肺动脉高压相关线粒体自噬生物标志物及其作用的分析与验证[J]. 广西医科大学学报,2024, 41(3): 419-429.
|
19 |
Luna-López R, Ruiz Martín A, EscribanoSubías P. Pulmonary arterial hypertension[J]. Med Clin(Barc), 2022, 158(12): 622-629.
|
20 |
Barman SA, Fulton D. Adventitial fibroblast Nox4 expression and ROS signaling in pulmonary arterial hypertension[J]. Adv Exp Med Biol, 2017, 967: 1-11.
|
21 |
Tian L, Wu D, Dasgupta A, et al. Epigenetic metabolic reprogramming of right ventricular fibroblasts in pulmonary arterial hypertension: A pyruvate dehydrogenase kinase-dependent shift in mitochondrial metabolism promotes right ventricular fibrosis[J]. Circ Res, 2020, 126(12): 1723-1745.
|
22 |
Thenappan T, Ormiston ML, Archer SL, et al. Pulmonary arterial hypertension:pathogenesis and clinical management[J]. BMJ, 2018, 360: j5492.
|
23 |
Chen L, Li M, Shen M, et al. Bioinformatics exploration of potential common therapeutic targets for systemic and pulmonary arterial hypertension-induced myocardial hypertrophy[J]. Acta BiochimBiophys Sin (Shanghai), 2023, 55(5): 831-841.
|
24 |
Jiao YR, Wang W, Lei PC, et al. 5-HTT,BMPR2,EDN1,ENG,KCNA5 gene polymorphisms and susceptibility to pulmonary arterial hypertension: A meta-analysis[J]. Gene, 2019, 680: 34-42.
|
25 |
Zhang W, Zhu T, Wu W, et al. LOX-1 mediated phenotypic switching of pulmonary arterial smooth muscle cells contributes to hypoxic pulmonary hypertension[J]. Eur J Pharmacol, 2018, 818: 84-95.
|
26 |
Tam AYY, Horwell AL, Trinder SL, et al. Selective deletion of connective tissue growth factor attenuates experimentally-induced pulmonary fibrosis and pulmonary arterial hypertension[J]. Int J Biochem Cell Biol, 2021, 134: 105961.
|
27 |
Abid S, Marcos E, Parpaleix A, et al. CCR2/CCR5-mediated macrophage-smooth muscle cell crosstalk in pulmonary hypertension[J]. Eur Respir J, 2019, 54(4): 1802308.
|
28 |
Jiang CY, Wu LW, Liu YW, et al. Identification of ACKR4 as an immune checkpoint in pulmonary arterial hypertension[J]. Front Immunol, 2023, 14: 1153573.
|
29 |
Samokhin AO, Stephens T, Wertheim BM, et al. NEDD9 targets COL3A1 to promote endothelial fibrosis and pulmonary arterial hypertension[J]. Sci Transl Med, 2018, 10(445): eaap7294.
|
30 |
王 琼,彭振辉,王万卷,等. RNAi对人类皮肤成纤维细胞COL1A1及COL3A1表达的影响[J]. 南方医科大学学报,2008, 28(1): 1-6.
|
31 |
Ferrian S, Cao A, McCaffrey EF, et al. Single-cell imaging maps inflammatory cell subsets to pulmonary arterial hypertension vasculopathy[J]. Am J Respir Crit Care Med, 2024, 209(2): 206-218.
|